This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Autoantibodies Against Specific Cytokines in Adults With Severe Mycobacterial Infection

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2012 by China Medical University Hospital.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
China Medical University Hospital Identifier:
First received: June 24, 2012
Last updated: June 26, 2012
Last verified: June 2012
In adult, the prevalence of mycobacterial infections is increased with age is largely unknown. IFN-gamma-IL-12/23 axis or NF-kappaB pathways might also plays crucial roles in adult against mycobacteria. Based on this hypothesis, the investigators had applied a functional assay to these pathways in patients with mycobacterial infection.

Mycobacterium Infection

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective

Resource links provided by NLM:

Further study details as provided by China Medical University Hospital:

Estimated Enrollment: 100
Study Start Date: January 2011
Estimated Study Completion Date: December 2014
Patients with mycobacterial infection


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Pateitns with Mycobacterium, Particular to the non Tuberculosis mycobacterium infection, in Taiwan

Inclusion Criteria:

  • Patients with mycobacterial infection

Exclusion Criteria:

  • Malignancy
  • Severe autoimmune
  • HIV infection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01628744

Contact: Cheng-?Lung KU, Ph.D (886) (0)3 211-8800 ext 3496

Graduate Institute of Clinical Medical Science, China Medical University Recruiting
Taichung, Taiwan
Principal Investigator: Chih Y. Chi, M.D,         
Sponsors and Collaborators
China Medical University Hospital
Principal Investigator: Cheng-Lung KU, Ph.D Graduate Institute of clinical Medical Science, China Medical Univerity, Taiwan
  More Information

Responsible Party: China Medical University Hospital Identifier: NCT01628744     History of Changes
Other Study ID Numbers: DMR-99-IRB-075-1
Study First Received: June 24, 2012
Last Updated: June 26, 2012

Additional relevant MeSH terms:
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections processed this record on August 23, 2017